一个25个月大的小孩意外里瓦洛克萨班中毒,用血栓显微镜监测:一个病例报告
Keita Nakanishi1, Shota Yamasaki2, Yuna Watanabe1
1Department of Pediatrics, Akashi Medical Hospital, Hyogo, Japan.
The Kobe journal of medical sciences
|February 19, 2026
概括
一名儿童不小心摄入了大量的里瓦洛克萨班. 血栓形成显微镜 (TEG® 6s) 监测显示,凝血功能在20小时内正常化,这表明它在儿科病例中的有用性.
科学领域:
- 儿科急救医学 儿科急救医学
- 药理学 药理学是指药理学的学科.
- 临床凝血 临床凝血
背景情况:
- 里瓦罗克萨班是一种直接作用的XA因子抑制剂.
- 血栓形成显微镜 (TEG® 6s) 评估凝血,通常用于外科手术.
- 有限的数据存在于TEG® 6s在儿科里瓦洛克萨班过量.
研究的目的:
- 报告一个儿科里瓦洛克萨班摄入病例.
- 评估TEG® 6s在过量服用后监测凝血的实用性.
- 评估儿童的安全性和康复性.
主要方法:
- 一个25个月大的女孩意外摄入了里瓦洛克萨班的案例报告.
- 使用TEG® 6s.进行连续的凝血监测.
- 对出血事件的临床观察.
主要成果:
- 在呈现时没有明显的出血.
- 摄入后大约20小时,TEG® 6s值恢复正常.
- 患者在没有并发症或出血的情况下出院.
结论:
- 在儿童过量服用里瓦洛克萨班时,TEG® 6s可能是监测里瓦洛克萨班效应的宝贵工具.
- 儿童意外摄入大剂量里瓦洛克萨班可以在密切观察下进行管理.
- 凝血参数的正常化表明,抗凝血剂效应的恢复.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


